Dr. Sheeja Pullarkat, MD

NPI: 1497793384
Total Payments
$213,828
2024 Payments
$64,847
Companies
4
Transactions
185
Medicare Patients
7,232
Medicare Billing
$1.1M

Payment Breakdown by Category

Other$174,612 (81.7%)
Travel$27,988 (13.1%)
Consulting$8,185 (3.8%)
Food & Beverage$2,953 (1.4%)
Education$90.50 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $88,752 23 41.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $85,860 21 40.2%
Travel and Lodging $27,988 103 13.1%
Consulting Fee $8,185 2 3.8%
Food and Beverage $2,953 34 1.4%
Education $90.50 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Stemline Therapeutics Inc. $113,851 94 $0 (2024)
Blueprint Medicines Corporation $92,871 87 $0 (2024)
Jazz Pharmaceuticals Inc. $4,481 2 $0 (2019)
EUSA Pharma (US) LLC $2,625 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $64,847 65 Blueprint Medicines Corporation ($56,211)
2023 $45,350 30 Stemline Therapeutics Inc. ($23,000)
2022 $47,179 36 Stemline Therapeutics Inc. ($32,855)
2021 $21,465 23 Stemline Therapeutics Inc. ($18,854)
2020 $5,815 5 Stemline Therapeutics Inc. ($5,815)
2019 $29,172 26 Stemline Therapeutics Inc. ($24,691)

All Payment Transactions

185 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/08/2024 Blueprint Medicines Corporation Food and Beverage In-kind items and services $108.18 General
12/02/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $6,468.00 General
12/02/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $4,620.00 General
12/02/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $4,004.00 General
12/02/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $1,232.00 General
12/02/2024 Blueprint Medicines Corporation Travel and Lodging Cash or cash equivalent $311.98 General
12/02/2024 Blueprint Medicines Corporation Food and Beverage Cash or cash equivalent $101.70 General
12/02/2024 Blueprint Medicines Corporation Travel and Lodging Cash or cash equivalent $58.00 General
12/02/2024 Blueprint Medicines Corporation Travel and Lodging Cash or cash equivalent $46.80 General
12/02/2024 Blueprint Medicines Corporation Food and Beverage Cash or cash equivalent $17.33 General
11/13/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $4,620.00 General
11/13/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $834.40 General
11/13/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $575.65 General
11/13/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $99.38 General
11/13/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $80.00 General
11/13/2024 Blueprint Medicines Corporation Travel and Lodging Cash or cash equivalent $63.44 General
11/12/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $316.90 General
11/08/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $286.70 General
11/07/2024 Blueprint Medicines Corporation Food and Beverage In-kind items and services $121.84 General
10/30/2024 Blueprint Medicines Corporation Food and Beverage In-kind items and services $120.85 General
10/24/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $370.96 General
10/24/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $339.01 General
10/24/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $80.00 General
10/15/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $5,236.00 General
10/15/2024 Blueprint Medicines Corporation Travel and Lodging Cash or cash equivalent $69.68 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 1,937 7,780 $2.5M $310,772
2022 22 1,823 6,573 $2.1M $266,768
2021 22 1,624 5,239 $1.7M $225,748
2020 23 1,848 5,530 $1.8M $256,157
Total Patients
7,232
Total Services
25,122
Medicare Billing
$1.1M
Procedure Codes
143

All Medicare Procedures & Services

143 procedure records from CMS Medicare Utilization — Page 1 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88185 Flow cytometry technique for dna or cell analysis, each additional marker Office 2023 169 3,802 $1.0M $77,089 7.6%
88377 Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure Office 2023 63 368 $416,100 $68,696 16.5%
88341 Special stained specimen slides to examine tissue, each additional procedure Office 2023 67 762 $192,035 $30,624 15.9%
88184 Flow cytometry technique for dna or cell analysis, first marker Office 2023 169 172 $74,820 $12,142 16.2%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Office 2023 162 165 $78,540 $11,674 14.9%
88377 Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure Facility 2023 60 207 $74,175 $11,209 15.1%
88313 Special stained specimen slides to examine tissue including interpretation and report Office 2023 61 250 $47,870 $9,625 20.1%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Facility 2023 116 129 $61,404 $9,175 14.9%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2023 56 340 $54,400 $8,217 15.1%
88360 Microscopic genetic analysis of tumor, manual Office 2023 49 146 $56,400 $7,985 14.2%
88237 Tissue culture for tumor disorders of bone marrow and blood cells Office 2023 53 53 $43,460 $7,466 17.2%
88342 Special stained specimen slides to examine tissue, initial procedure Office 2023 71 142 $38,812 $6,576 16.9%
88262 Chromosome analysis for genetic defects, count 15-20 cells Office 2023 53 53 $42,930 $6,518 15.2%
88368 Microscopic genetic analysis of tissue, manual, initial procedure Office 2023 49 97 $53,579 $6,414 12.0%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 67 179 $50,042 $5,833 11.7%
88369 Microscopic genetic analysis of tissue, manual, each additional procedure Office 2023 31 84 $24,990 $4,803 19.2%
88365 Genetic sequencing localization, initial procedure Office 2023 17 34 $16,830 $3,448 20.5%
85097 Bone marrow, smear interpretation Office 2023 53 53 $23,903 $3,267 13.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 47 70 $12,348 $2,227 18.0%
88360 Microscopic genetic analysis of tumor, manual Facility 2023 42 56 $16,800 $1,995 11.9%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 55 61 $11,651 $1,814 15.6%
88368 Microscopic genetic analysis of tissue, manual, initial procedure Facility 2023 47 48 $14,352 $1,705 11.9%
88291 Interpretation and report of genetic testing Office 2023 53 53 $9,275 $1,521 16.4%
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers Facility 2023 23 28 $11,032 $1,493 13.5%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2023 17 20 $8,000 $1,409 17.6%

About Dr. Sheeja Pullarkat, MD

Dr. Sheeja Pullarkat, MD is a Anatomic Pathology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497793384.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheeja Pullarkat, MD has received a total of $213,828 in payments from pharmaceutical and medical device companies, with $64,847 received in 2024. These payments were reported across 185 transactions from 4 companies. The most common payment nature is "Honoraria" ($88,752).

As a Medicare-enrolled provider, Pullarkat has provided services to 7,232 Medicare beneficiaries, totaling 25,122 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.

Practice Information

  • Specialty Anatomic Pathology
  • Location Los Angeles, CA
  • Active Since 06/03/2006
  • Last Updated 11/22/2019
  • Taxonomy Code 207ZP0101X
  • Entity Type Individual
  • NPI Number 1497793384

Products in Payments

  • ELZONRIS (Drug) $63,942
  • AYVAKIT (Drug) $13,651
  • Sylvant (Drug) $2,625

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology Doctors in Los Angeles